Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance
Clinical trial NCT04230499 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04230499
- Sponsor
- Rapamycin Holdings Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-18
- Primary completion
- 2025-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.